Skip to main content

Fatal poisoning among people who use drugs in Denmark in 2022

Charlotte Uggerhøj Andersen1, Simon Kjær Hermansen2, Kristine Boisen Olsen3, Kristian Linnet4 & Kirsten Wiese Simonsen4

15. okt. 2025
13 min.

Abstract

Since 1970, a legal autopsy and systematic toxicological analysis have been mandatory for all deaths suspected to involve narcotic drugs in Denmark [1]. This enables a comprehensive evaluation of the causes of death among people who use drugs (PWUD) based on data from the Danish Departments of Forensic Medicine. Toxicological analyses identify the primary intoxicants as well as other substances present in the deceased’s blood. Consequently, surveys of fatal poisonings among Danish PWUD offer valuable insights into current trends and the risks associated with drug use. For this reason, Danish toxicological findings in PWUD have been reported every fifth year since 1991.

Overdose deaths from medicinal opioids increased in Europe in 2022, while deaths from synthetic fentanyls and nitazenes have been limited [2]. Overdose deaths from synthetic fentanyls surged in the USA in 2022, while deaths from prescription medicine remained at a high level [3].

Prescribed opioids, such as oxycodone and tramadol, have recently entered the illegal market in Denmark and are sold illegally from kiosks [4]. However, most young people who begin using opioids receive or buy them from friends/acquaintances. In 2023, Danish customs officials confiscated almost one million opioid tablets, representing a five-fold increase since 2021 [5]. This rising demand suggests a growing trend of medicinal opioid abuse, and this kind of abuse among young people has raised concerns among Danish authorities [6].

This study aimed to describe the main intoxicants and detected drugs among PWUD dying from drug poisoning in Denmark in 2022 and to compare these findings with previous studies.

Data from the present study and data from previous reports were included in a joint Nordic study [7].

METHODS

All fatal poisonings among PWUD who underwent legal autopsy at the three Danish Departments of Forensic Medicine - in Copenhagen, Aarhus and Odense, collectively covering the entire country - were included in the study.

The PWUD definition was consistent with that used in previous studies [8-13]: “a person who, according to information from the police and/or autopsy report, is known to have abused drugs intravenously and/or abused drugs listed in the Single Convention on Narcotic Drugs 1961, Schedule I (heroin, morphine, ketobemidone, cocaine, etc.), and/or the International Convention on Psychotropic Substances 1971, Schedules I and II (amphetamine, methamphetamine, MDMA (ecstasy), LSD, tetrahydrocannabinol (THC) etc.)”.

We recorded data from autopsy reports, including gender, age, main intoxicants and other drugs detected in blood. Fatal poisonings involving two or more drugs were categorised based on the drug deemed to have been the main intoxicant.

Heroin is rapidly metabolised to morphine and detected as such in toxicological screens; therefore, cases in which morphine was detected were listed as heroin/morphine cases.

The sum of fatal poisonings was compared across geographical areas by normalising it to the number of inhabitants aged 15-69 years. Only two PWUD fell outside this age range.

Information about opioid maintenance treatment was obtained from autopsy reports. The data presented are minimum figures, as the information was not always available.

Ethics

According to Section 14 of the Consolidation Act on Research Ethics Review of Health Research Projects, Consolidation Act number 1083 of 15 September 2017 [2], this project did not need approval from the Committees on Health Research Ethics. The study was registered at the University of Copenhagen, Aarhus University and the University of Southern Denmark. All data were handled in accordance with the General Data Protection Regulation (GDPR) and the Danish Data Protection Act.

Fakta

RESULTS

Number of deaths

The declining trend in the number of fatal poisonings among PWUD observed since 2012 was reversed in 2022, with the number of deaths surpassing those recorded in 2017, primarily due to an increase in deaths in the Copenhagen and Aarhus areas (Figure 1). Although the absolute number of deaths was highest in Copenhagen, the number of deaths per 100,000 inhabitants in the 15-69-year age group was highest in the Odense area (5.8), followed by Copenhagen (5.0) and Aarhus (4.3).

Characteristics of cases

In 2022, 199 fatal poisonings occurred among PWUD. The manners of death were accidental (77%), suicide (5%) or unknown (18%). The proportion of women increased from 15% in 2017 to 23% in 2022 [13]. The median age was 42 (range: 16-73) years, which is similar to the median age recorded in 2017 [13]. Overall, 24% of PWUD were prescribed methadone and 4% were prescribed buprenorphine at the time of death. In 62% of the cases, the available information indicated that the individual was alone at the time of death.

Main intoxicants

Poisoning with multiple substances occurred in 42% of the cases. A combination of an opioid and a benzodiazepine was involved in 78% of these cases.

As previously reported, opioids caused the greatest number of deaths. However, the proportion of fatal poisonings mainly caused by opioids decreased to 73% in 2022 from 82% in 2017, 87% in 2012 and 99% in 1997. Among PWUD undergoing methadone treatment, methadone either alone or in combination with other substances was deemed the cause of 81% of the fatal poisonings. Buprenorphine contributed to the cause of death in 38% of those undergoing buprenorphine treatment.

Methadone has been the most frequent main intoxicant since 2007, a trend that persisted into 2022. However, the number of deaths caused mainly by methadone has decreased in all parts of Denmark since 2007 or 2012 (Figure 2 A). Heroin/morphine was the second most common main intoxicant in 2022, although the number of heroin/morphine deaths has shown a steady decrease since 1997 (Table 1), particularly in the area covered by Copenhagen (Figure 2 A).

Fatal poisonings with oxycodone and buprenorphine increased in 2022 compared to previous years, and tramadol caused 1.5% of deaths (Table 1).

The proportion of deaths from the central stimulants: cocaine, amphetamine and MDMA increased from 1-6% in early studies to 13% in 2017 and then to 17% in 2022, with cocaine being responsible for most deaths (Table 1). The proportion of deaths caused by cocaine was 2-3 times higher in the area covered by Copenhagen (15%) than in the areas covered by Aarhus (7.6%) or Odense (5.4%).

A few deaths occurred due to methamphetamine, gamma-hydroxybutyrate (GHB), pregabalin, chlordiazepoxide, butane (lighter gas) and nitrite. The new psychoactive substances (NPS) 3-chlormethcatinone and metonitazene were responsible for 2% of the deaths. Antidepressants/antipsychotics and ethanol caused 2.5% and 2% of the deaths, respectively.

Pattern of detected drugs

The median number of detected drugs per case was five (excluding ethanol) and unchanged compared to 2017. The three most detected drugs (excluding THC) were methadone, cocaine and clonazepam, which were detected in 52%, 45% and 35% of the cases, respectively (Table 2).

The proportion of cases positive for methadone (52%) and heroin/morphine (26%) decreased across all areas from the 2017 values of 65% and 35%, respectively [13]. The proportion of cases positive for heroin/morphine was largest in the area covered by Odense, whereas methadone was more frequent in the areas covered by Copenhagen and Aarhus (Table 2).

The proportion of cases positive for oxycodone (9%) and tramadol (7%) increased compared to 2017, whereas that of buprenorphine remained unaltered [13]. Buprenorphine and oxycodone were most frequently detected in the western part of Denmark, whereas tramadol was slightly more frequent in the area covered by Copenhagen (Table 2).

The proportion of cases involving cocaine remained high, as 45% were positive for cocaine, as seen in 2017. The area covered by Odense had the lowest proportion of cocaine-positive cases (Table 2). However, the proportion increased from 22% in 2017 to 32% in 2022 [13]. The proportion of amphetamine-positive cases nearly doubled from 11% in 2017 to 20% in 2022 [13]. This increase was most pronounced in the area covered by Odense. Overall, cocaine and amphetamines were most frequently detected in the area covered by Aarhus (Table 2). The proportion of MDMA-positive cases remained unchanged compared to 2017, and MDMA was detected only in the areas covered by Copenhagen and Aarhus (Table 2).

The gabapentinoids pregabalin and gabapentin were found in twice as many cases as in 2017 [13]. This increase was observed in all parts of Denmark.

Clonazepam, alprazolam and diazepam were the most frequently detected benzodiazepines, detected in 35%, 23% and 14% of cases, respectively. Compared to 2017, the frequency of clonazepam and diazepam decreased from 45% and 29%, respectively, while the frequency of alprazolam increased from 13% [13].

NPS were detected in 7.5% of the cases. Nitazenes, metonitazene and etodesnitazene, which are opioids, appeared for the first time, but were only detected in less than 2% of cases. The stimulant NPS 3-chloromethcathinone was observed in less than 1.5% of the cases. Among the NPS benzodiazepines, etizolam was detected in 3.5% of cases, whereas bromazolam, clonazolam and flualprazolam were detected only sporadically.

Similar to 2017, nearly half (48%) of all cases were positive for one or more antidepressant or antipsychotic drugs [13]. Quetiapine and olanzapine were the most common antipsychotics, whereas mirtazapine and sertraline were the most frequently seen antidepressants.

Pattern of detected drugs in different age groups

Heroin/morphine, methadone and buprenorphine were twice as frequent in PWUD above age 45 years as among those aged 15-25 years, whereas oxycodone and tramadol were 5-6 times more frequent in the 15-25-year age group than in the above 45-year age group (Figure 2 B). Cocaine was detected twice as often among 15- to 25-year-olds as in PWUD above 45 years of age, whereas amphetamine detection was slightly more frequent (1.2 times) in PWUD older than 45 years of age than in 15- to 25-year-olds (Figure 2 B).

DISCUSSION

The present study showed that while poisonings caused by the most common substances (e.g. methadone and heroin/morphine) seemingly decreased slightly, deaths from other opioids (e.g. oxycodone, tramadol, buprenorphine and fentanyl) and from cocaine and amphetamine have increased. The proportion of cases in which 'other drugs' were identified as the main intoxicant was also higher in 2022 than previously. Furthermore, NPS, including a nitazene, caused a few deaths. Some nitazene opioids have a potency comparable to or even higher than that of fentanyl [14]. Fentanyl is considered to be 100 times more potent than morphine and is responsible for numerous fatal poisonings in the USA [15]. Fortunately, no such trend has yet been observed in Denmark. Like fentanyl, nitazenes pose a significant risk of overdose, as even minimal amounts can cause lethal central nervous system inhibition and respiratory depression. New nitazenes continue to emerge in the European illicit drug market [15], and their appearance in the present study aligns with this trend. Overall, the 2022 results suggest a greater diversity of main intoxicants than observed previously. Furthermore, the demographics of PWUD may have changed, as we noted a higher proportion of women. This should be considered in future prophylactic strategies.

The pattern of detected drugs varied somewhat between regions, as heroin/morphine seems to be used more frequently in the area covered by Odense, whereas cocaine and amphetamine seem more prevalent in the area covered by Aarhus. The use of the gabapentinoids gabapentin and pregabalin increased over time in this study and in general [16]. These drugs are currently not categorised as controlled substances in Denmark, and neither was tramadol until recently. In 2017, the Danish Medicines Agency introduced stricter reporting of adverse effects for medicines containing tramadol [17], confirming that tramadol addiction could occur even after treatment with therapeutic doses [17]. Furthermore, the Customs Agency seized increasing amounts of tramadol. In April 2022, tramadol changed status to a controlled substance in Denmark [18]. In the present study, tramadol was the main intoxicant in a limited number of deaths; however, the detection of tramadol in 7% of the poisoned PWUD overall, and in 14% of those aged 15-25 years, supports imposing opioid-type controls on tramadol.

According to a recent Danish questionnaire survey, 3.7% of persons aged 20-29 years had used medicinal opioids for recreational purposes [6]. The present study substantiates concerns raised in the survey regarding illicit use of medicinal opioid tablets among young individuals, as oxycodone and tramadol were most frequently detected among decedents aged 15-25 years. This concern is especially pertinent in light of a tenfold increase in oxycodone deaths. We recommend that adequate treatment be ensured for young people with opioid addiction to prevent this development.

The increasing frequency of cocaine and amphetamine as the main intoxicants and detected drugs is also in line with globally observed trends showing increased trafficking and seizures of these drugs [15]. In the questionnaire survey [6], 14% of the 20 to 29-year-old respondents had tried cocaine, and the increasing rate of deaths indicates that preventive measures targeting central stimulants should also be prioritised. Although we regard opioids as the most toxic drugs in terms of fatal poisonings, the increasingly frequent use of cocaine and amphetamines may result in more deaths if the trend continues.

CONCLUSIONS

Our results indicate an increasing diversity of opioids causing fatal poisonings in PWUD and a rising detection rate and proportion of deaths linked to central stimulants. Central to our concern is the rising incidence of fatalities among young individuals who use medicinal opioids, such as oxycodone and tramadol.

Correspondence Kirsten Wiese Simonsen. E-mail: kirsten.wiese@sund.ku.dk

Accepted 18 July 2025

Published 15 October 2025

Conflicts of interest none. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. These are available together with the article at ugeskriftet.dk/dmj

References can be found with the article at ugeskriftet.dk/dmj

Cite this as Dan Med J 2025;72(11):A03250147

doi 10.61409/A03250147

Open Access under Creative Commons License CC BY-NC-ND 4.0

Referencer

  1. Danish Ministry of Justice. [Circular letter on the performance of statutory autopsy in cases of deaths suspected of being related to the abuse of euphoric substances]. Danish Ministry of Justice, 1970. www.retsinformation.dk/eli/mt/1970/254 (Aug 2025)
  2. European Union Drugs Agency (EUDA). European drug report 2024: trends and developments. www.euda.europa.eu/publications/european-drug-report/2024_en (Aug 2025)
  3. National Institute on Drug Abuse. Drug overdose deaths: facts and figures. National Institute on Drug Abuse, 2024. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates (Aug 2025)
  4. Danish Health Authority. [Survey on young people on use of opioids and benzodiazepines]. www.sst.dk/-/media/Udgivelser/2024/Stoffer/Undersoegelse-blandt-unge-om-brug-af-opioider-og-benzodiazepiner.ashx (Aug 2025)
  5. Danish Ministry of Taxation. [Fivefold increase: customs officers find more euphoric pills than ever before]. Danish Ministry of Taxation, 2024. https://skm.dk/aktuelt/presse-nyheder/pressemeddelelser/femdobling-toldere-finder-flere-euforiserende-piller-end-nogensinde-foer (Aug 2025)
  6. Nygaard-Christensen M, Thylstrup B, Houborg E, et al. [Use of prescription opioids among young people in Denmark: results from qualitative and quantitative studies]. Center for Rusmiddelforskning, Aarhus Universitet, 2024. https://psy.au.dk/fileadmin/site_files/filer_rusmiddelforskning/dokumenter/rapporter/2024/Brug_af_receptpligtige_opioider_blandt_unge_i_Danmark_Rapport_fra_Center_for_Rusmiddelforskning_Aarhus_Universitet._Juli_2024.pdf (Aug 2025)
  7. Kriikku P, Edvardsen HME, Thelander G, et al. Fatal poisonings in Nordic countries in 2022 among people who use drugs. Forens Sci Int Rep. 2025;11:100408 https://doi.org/10.1016/j.fsir.2025.100408
  8. Steentoft A, Kaa E, Simonsen KW, et al. [Deaths among drug addicts in Denmark: a forensic medical study of deaths among drug addicts during the period 1991-1992 related to the period 1984-1985]. Ugeskr Læger. 1994;156:6215-6219
  9. Steentoft A, Simonsen KW, Kringsholm B, et al. [Fatal intoxications among drug addicts in Denmark in 1997]. Ugeskr Læger. 2000;162:5205-5208
  10. Steentoft A, Kringsholm B, Hansen AC, et al. [Fatal poisonings among drug addicts in Denmark in 2002]. Ugeskr Læger. 2005;167(18):1954-1957
  11. Simonsen KW, Hansen AC, Rollmann D, et al. Drug-related death in Denmark 2007. Dan Med Bull. 2011;58(8):A4307
  12. Simonsen KW, Christoffersen DJ, Banner J, et al. Fatal poisoning among patients with drug addiction. Dan Med J. 2015;62(10):A5147
  13. Simonsen KW, Christoffersen DJ, Linnet K, Andersen CU. Fatal poisoning among drug users in Denmark in 2017. Dan Med J. 2021;68(1):A07200560
  14. Vandeputte MM, van Uytfanghe K, Layle NK, et al. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of "nitazene" 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci. 2021;12(7):1241-1251 https://doi.org/10.1021/acschemneuro.1c00064
  15. United Nations Office on Drugs and Crime. World Drug Report 2024. United Nations, 2024. www.unodc.org/documents/data-and-analysis/WDR_2024/WDR24_Key_findings_and_conclusions.pdf (Aug 2025)
  16. McNeilage AG, Sim A, Nielsen S, et al. Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review. Int J Drug Policy. 2024;133:104605 https://doi.org/10.1016/j.drugpo.2024.104605
  17. Danish Medicines Agency. [Adverse reaction reports on tramadol addiction]. Danish Medicines Agency, 2018. https://laegemiddelstyrelsen.dk/da/udgivelser/2018/bivirkningsindberetninger-om-afhaengighed-ved-tramadol/ (Aug 2025)
  18. Danish Medicines Agency. [Executive order on euphoriant drugs: 7 new drugs added including tramadol]. Danish Medicines Agency, 2022. https://laegemiddelstyrelsen.dk/da/nyheder/2022/bekendtgoerelse-om-euforiserende-stoffer-7-nye-stoffer-tilfoejet-inkl-tramadol/ (Aug 2025)